Covetrus Inc (NASDAQ:CVET) insider Timothy Ludlow sold 81,498 shares of the firm’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $28.01, for a total transaction of $2,282,758.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
NASDAQ:CVET traded down $0.07 on Tuesday, reaching $28.05. 1,005,807 shares of the stock traded hands, compared to its average volume of 1,547,242. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.82 and a quick ratio of 0.91. Covetrus Inc has a 1-year low of $27.02 and a 1-year high of $43.83.
Covetrus (NASDAQ:CVET) last released its earnings results on Wednesday, May 15th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.03). The business had revenue of $941.00 million for the quarter, compared to analyst estimates of $993.41 million. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the company earned $0.18 earnings per share. As a group, equities research analysts anticipate that Covetrus Inc will post 0.68 earnings per share for the current year.
Covetrus Company Profile
Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.
Recommended Story: The Role of a Fiduciary and Individual Investors
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.